Nephros (NEPH) Income from Continuing Operations (2010 - 2026)
Nephros (NEPH) recorded quarterly Income from Continuing Operations of 129000.0 in Q1 2026, up 108.06% quarter-over-quarter from 62000.0 in Q4 2025, and down 77.72% on a YoY basis from 579000.0 in Q1 2025.
Nephros (NEPH) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Nephros' Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 129000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 77.72% year-over-year to 129000.0; the TTM figure through Mar 2026 stood at 765000.0 (down 8.6% YoY), while the FY2025 annual figure was 1194000.0, up 1513.51% from the prior year.
- Income from Continuing Operations was 129000.0 for Q1 2026 at Nephros, up from 62000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 579000.0 in Q1 2025 to a low of 1554000.0 in Q1 2022.
- Historically, Income from Continuing Operations has averaged 261647.06 across 5 years, with a median of 192000.0 in 2023.
- Biggest YoY gain for Income from Continuing Operations was 428.98% in 2025; the steepest drop was 82.97% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 689000.0 in 2022, then grew by 9.72% to 622000.0 in 2023, then surged by 158.52% to 364000.0 in 2024, then plunged by 82.97% to 62000.0 in 2025, then jumped by 108.06% to 129000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 129000.0 (Q1 2026), 62000.0 (Q4 2025), and 337000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -37.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -17.00 Mn |
| 10 | Nephros | 34.19 Mn | 30.17 Mn | 2.99 Mn | 129,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 129,000.00 |
| Dec 31, 2025 | 62,000.00 |
| Sep 30, 2025 | 337,000.00 |
| Jun 30, 2025 | 237,000.00 |
| Mar 31, 2025 | 579,000.00 |
| Dec 31, 2024 | 364,000.00 |
| Sep 30, 2024 | 183,000.00 |
| Jun 30, 2024 | -289,000.00 |
| Mar 31, 2024 | -176,000.00 |
| Dec 31, 2023 | -622,000.00 |
| Sep 30, 2023 | -192,000.00 |
| Jun 30, 2023 | -422,000.00 |
| Mar 31, 2023 | -295,000.00 |
| Dec 31, 2022 | -689,000.00 |
| Sep 30, 2022 | -1.28 Mn |
| Jun 30, 2022 | -819,000.00 |
| Mar 31, 2022 | -1.55 Mn |
| Dec 31, 2021 | -726,000.00 |
| Sep 30, 2021 | -810,000.00 |
| Jun 30, 2021 | -1.13 Mn |